We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.55 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
24/4/2021 10:53 | The delusion is real...taking about “yeah but we don’t know the opening price yet” You have been diluted to oblivion so you don’t need to worry about the price - the damage is done When Iclaprim was taken out of the deal here - that was the last line of defence for LTH in Motif - oblivion awaits here | scottdavid70 | |
24/4/2021 10:50 | Just by BOU who Robblertwo has been promoting as a case study for RTO’s - appropriate consolidation looks like 500-1 here....how’s that feeling for everyone along with a fundraise? Remember when Lumsden kept you locked in with no clinical trials when the price was fluctuating around 9p and then all bases covered at 4p? How’s that all sitting in the throat right now? More annoyed by my posts highlighting what’s gone on here? | scottdavid70 | |
24/4/2021 10:35 | If anyone in the group of companies ‘helping’ Jonathan Gold would also come out and say that he has been working for free since failing to get the RTO done by the end of January as it was supposed to be done. Investors have taken all the risk and the Directors are under rules committing them to act in shareholders best interests. Clearly paying more money to Directors for missing deadlines, thereby indirectly incentivising them to actually miss deadlines and bonuses to Directors who have caused cataclysmic wealth destruction isn’t in shareholders best interests. | scottdavid70 | |
23/4/2021 22:56 | Not one person on here on LSE disputed this was now the most likely reason and outcome as to why Orange Avenue Technologies LLC was set up Courtesy of DavidUncle on LSE “Orange Avenue Technologies LLC As I understand it - this was set up now to take Iclaprim out of Motif Bio so that when the RTO doesn't happen or potentially doesn't happen they can still profit from it hence the secrecy surrounding anything to do with this company bar knowing John Palmer owns it. That makes a lot of sense if true. They have ringed fenced the asset for themselves. Until we hear otherwise this hypothesis is the one I tend to now agree with” Lemmings and lambs to the slaughter | scottdavid70 | |
23/4/2021 10:42 | Not true Chuffer actually but I do agree things are very bleak here now and things have been done to keep upside for the Board in the future with the only man who couldn’t sell Iclaprim over 18 months still holding the keys to the asset. How else do you explain it. | scottdavid70 | |
23/4/2021 10:23 | Courtesy of DavidUncle on LSE “Orange Avenue Technologies LLC As I understand it - this was set up now to take Iclaprim out of Motif Bio so that when the RTO doesn't happen or potentially doesn't happen they can still profit from it hence the secrecy surrounding anything to do with this company bar knowing John Palmer owns it. That makes a lot of sense if true. They have ringed fenced the asset for themselves. Until we hear otherwise this hypothesis is the one I tend to now agree with” | scottdavid70 | |
23/4/2021 10:18 | Interesting post this morning on LSE about Orange Avenue Technologies LLC- might make the most sense of what undoubtedly was a very weird development As I have said the audit in my humble opinion is a massive red herring- bigger than Tony Blair’s weapons of mass destruction | scottdavid70 | |
22/4/2021 20:39 | Remember the RTO was touted originally as due to the potential created by COViD - remember that RNS? Covid they said but funnily enough it’s got nothing to do with Covid Laughable stuff every time from this Board of Clowns | scottdavid70 | |
22/4/2021 19:15 | No one that has been invested here since anytime from 2019 and any poor soils invested before then - well I feel for you but you know the drill - zero chance given Motifs history or Graham Lumsdens of an RNS announcement being in April | scottdavid70 | |
22/4/2021 18:52 | I have had more marketing today from the Jehovah’s Witnesses and Woolworths today than any miraculous RTO at Motif Bio Had more information on the benefits of eating kale than a multi billion dollar antibiotic Woolworths I found out has been busy for over a year as well!! | scottdavid70 | |
22/4/2021 17:56 | Tomorrow's the end of April?? | small crow | |
22/4/2021 17:36 | Well it's tomorrow or there must be some more paperwork to finish lol | tnt99 | |
22/4/2021 06:37 | RNS - 29 Mar 21"As such, should the Proposed Transaction proceed, it is expected that Motif will now publish the AIM Admission Document in late April or early May 2021.At present there can be no assurances that Motif will be able to complete the Proposed Transaction and as a consequence the Company's admission to trading on AIM may be cancelled."Not much longer to wait. Fingers crossed for a positive outcome. | lithological heterogeneities | |
21/4/2021 20:23 | Don’t forget to am appropriate level of consolidation in your shares means nothing to those making that decision. They haven’t bought any with their money - doesn’t hurt them at Easy for them to obliterate your holding | scottdavid70 | |
21/4/2021 20:01 | If Carlsberg did marketing like Motif Bio their beer would still be popular Lumsden and Gold showing Saatchi and Saatchi how to do it. Feel like I am watching the Super Bowl half time ads with the publicity for Motifs RTO and Iclaprim sale. Wow | scottdavid70 | |
21/4/2021 10:59 | Do we think BIOMARCK shareholders knew that Graham Lumsden didn’t do a Corporate Governance review in 2019? Had he done so on the back of a terrible and disastrous year at the helm of Motif Bio would he have been hired? That review could have been crucial | scottdavid70 | |
21/4/2021 10:55 | Motif Bio were needing Warren Buffett and sadly got Little Miss Moffat | scottdavid70 | |
21/4/2021 10:01 | Morning all ,,,, er, Scott. | small crow | |
21/4/2021 09:58 | Just like tor owners of EPL clubs the owners aren’t as powerful as they think they are - same here - collective pressure from shareholders means accountability for shareholders from Directors. Don’t lose sight of what you can all achieve if you act your rather individuals | scottdavid70 | |
21/4/2021 07:31 | Motif Bio - Walbrook PR (you would think being PR they would know better) and Jonathan Gold and Graham Lumsden haven’t quite worked out this marketing and advertising thing have they? Zero on the RTO and zero on Iclaprim publicly apart from a pre-school 2 pager A4 on John Palmer’s LinkedIn page. For the millions they have snaffled in investors cash for themselves you think they could have spent a few bob on getting the story out there | scottdavid70 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions